179 related articles for article (PubMed ID: 11585484)
1. Coprescribing and codispensing of cisapride and contraindicated drugs.
Jones JK; Fife D; Curkendall S; Goehring E; Guo JJ; Shannon M
JAMA; 2001 Oct; 286(13):1607-9. PubMed ID: 11585484
[TBL] [Abstract][Full Text] [Related]
2. Contraindicated medications dispensed with cisapride: temporal trends in relation to the sending of 'Dear Doctor' letters.
Weatherby LB; Walker AM; Fife D; Vervaet P; Klausner MA
Pharmacoepidemiol Drug Saf; 2001 May; 10(3):211-8. PubMed ID: 11501334
[TBL] [Abstract][Full Text] [Related]
3. Co-dispensing of contraindicated medications in patients using cisapride in Italy.
Staniscia T; Romano F; Festi D; Bilker WB; Macones GA; Strom BL
Pharmacoepidemiol Drug Saf; 2006 Jul; 15(7):469-76. PubMed ID: 16700085
[TBL] [Abstract][Full Text] [Related]
4. Impact of cisapride label changes on codispensing of contraindicated medications.
Guo JJ; Curkendall S; Jones JK; Fife D; Goehring E; She D
Pharmacoepidemiol Drug Saf; 2003 Jun; 12(4):295-301. PubMed ID: 12812009
[TBL] [Abstract][Full Text] [Related]
5. Contraindicated use of cisapride: impact of food and drug administration regulatory action.
Smalley W; Shatin D; Wysowski DK; Gurwitz J; Andrade SE; Goodman M; Chan KA; Platt R; Schech SD; Ray WA
JAMA; 2000 Dec; 284(23):3036-9. PubMed ID: 11122591
[TBL] [Abstract][Full Text] [Related]
6. The impact of wording in "Dear doctor" letters and in black box labels.
Weatherby LB; Nordstrom BL; Fife D; Walker AM
Clin Pharmacol Ther; 2002 Dec; 72(6):735-42. PubMed ID: 12496755
[TBL] [Abstract][Full Text] [Related]
7. Increase in mortality rate following coprescription of cisapride and contraindicated drugs.
Choi NK; Hahn S; Park BJ
Ann Pharmacother; 2007 Apr; 41(4):667-73. PubMed ID: 17374629
[TBL] [Abstract][Full Text] [Related]
8. The coprescription of contraindicated drugs with statins: continuing potential for increased risk of adverse events.
Stang P; Morris L; Kempf J; Henderson S; Yood MU; Oliveria S
Am J Ther; 2007; 14(1):30-40. PubMed ID: 17303973
[TBL] [Abstract][Full Text] [Related]
9. Impact of safety warnings on drug utilization: marketplace life span of cisapride and troglitazone.
Wilkinson JJ; Force RW; Cady PS
Pharmacotherapy; 2004 Aug; 24(8):978-86. PubMed ID: 15338846
[TBL] [Abstract][Full Text] [Related]
10. Filled prescriptions of age-related contraindicated drugs in children: a one-year nationwide cohort study in the Netherlands.
Cheung K; Teichert M; Moll HA; Stricker BH; Visser LE
Int J Clin Pharm; 2018 Oct; 40(5):1137-1143. PubMed ID: 30136053
[TBL] [Abstract][Full Text] [Related]
11. Usage of the claim database of national health insurance programme for analysis of cisapride-erythromycin co-medication in Taiwan.
Gau CS; Chang IS; Lin Wu FL; Yu HT; Huang YW; Chi CL; Chien SY; Lin KM; Liu MY; Wang HP
Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):86-95. PubMed ID: 17006967
[TBL] [Abstract][Full Text] [Related]
12. Prokinetics prescribing in paediatrics: evidence on cisapride, domperidone, and metoclopramide.
Mt-Isa S; Tomlin S; Sutcliffe A; Underwood M; Williamson P; Croft NM; Ashby D
J Pediatr Gastroenterol Nutr; 2015 Apr; 60(4):508-14. PubMed ID: 25825854
[TBL] [Abstract][Full Text] [Related]
13. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of H2-receptor antagonists.
Andrade SE; Gurwitz JH; Fish LS
Med Care; 1999 Apr; 37(4):424-30. PubMed ID: 10213023
[TBL] [Abstract][Full Text] [Related]
14. Preventing drug interactions by online prescription screening in community pharmacies and medical practices.
Halkin H; Katzir I; Kurman I; Jan J; Malkin BB
Clin Pharmacol Ther; 2001 Apr; 69(4):260-5. PubMed ID: 11309555
[TBL] [Abstract][Full Text] [Related]
15. Isotretinoin use and compliance with the Dutch Pregnancy Prevention Programme: a retrospective cohort study in females of reproductive age using pharmacy dispensing data.
Teichert M; Visser LE; Dufour M; Rodenburg E; Straus SM; De Smet PA; Stricker BH
Drug Saf; 2010 Apr; 33(4):315-26. PubMed ID: 20297863
[TBL] [Abstract][Full Text] [Related]
16. Time trends in the coprescribing of cisapride and contraindicated drugs in Umbria, Italy.
Raschetti R; Maggini M; Da Cas R; Popoli P; Rossi A
JAMA; 2001 Apr; 285(14):1840-1. PubMed ID: 11308395
[No Abstract] [Full Text] [Related]
17. Prevalence of unclaimed prescriptions at military pharmacies.
Esposito D; Schone E; Williams T; Liu S; CyBulski K; Stapulonis R; Clusen N
J Manag Care Pharm; 2008; 14(6):541-52. PubMed ID: 18693778
[TBL] [Abstract][Full Text] [Related]
18. The risk of serious cardiac arrhythmias among cisapride users in the United Kingdom and Canada.
Walker AM; Szneke P; Weatherby LB; Dicker LW; Lanza LL; Loughlin JE; Yee CL; Dreyer NA
Am J Med; 1999 Oct; 107(4):356-62. PubMed ID: 10527038
[TBL] [Abstract][Full Text] [Related]
19. [Risk of drug interactions. Combinations of drugs associated with ventricular arrhythmias].
Viramontes-Madrid JL; Jerjes-Sánchez C; Pelaez-Ballestas I; Aguilar-Chiu A; Hernández-Garduño AG
Rev Invest Clin; 2002; 54(3):192-7. PubMed ID: 12183887
[TBL] [Abstract][Full Text] [Related]
20. Unclaimed prescriptions after automated prescription transmittals to pharmacies.
Ekedahl A; Månsson N
Pharm World Sci; 2004 Feb; 26(1):26-31. PubMed ID: 15018256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
